Parkinson’s Disease
Conditions
Interventions
This is a two-arm randomized clinical study with outcome assessors blinded to participant allocation. Twenty participants will be randomly assigned to two equal groups (G1 and G2) using a sequence gen
equipment switching will be allowed until the 3rd session if adaptation difficulties occur, and the prescription will be individualized according to each participant’s physical capacity and adaptation
progression will be individualized by increasing load, speed, and exercise complexity according to participant response. Intensity will be monitored using the Borg scale and daily records, allowing in
G11.427.410.698.277
Sponsors
Universidade Federal do Triângulo Mineiro
Universidade Federal do Triângulo Mineiro
Eligibility
Age
30 Years to No maximum
Inclusion criteria
Inclusion criteria: Individuals diagnosed with Parkinson’s disease; minimum age of 30 years; both sexes; varying levels of education; currently at stages I, II, or III on the Hoehn & Yahr scale
Exclusion criteria
Exclusion criteria: Individuals who present acute osteomyoarticular injuries or limiting cardiac alterations; Dementia; Uncontrolled severe psychiatric illness or current psychotic symptoms, which would be characterized as a contraindication for the practice of physical activity; Unjustified absence; clinical instabilityity practice
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in participants’ functional capacity is expected. The outcome will be assessed using the 6-minute walk test (6MWT), evaluating the total distance walked, comparing pre- and post-intervention values;Improvement in participants’ quality of life is expected. The outcome will be assessed using the Parkinson’s Disease Questionnaire-39 (PDQ-39), evaluating total and domain scores, comparing pre- and post-intervention values;Improvements in gait parameters are expected. The results will be assessed using the Dynamic Gait Index (DGI), which evaluates the total score and performance on functional gait tasks, comparing pre- and post-intervention values;Improvements in balance parameters are expected. The results will be assessed using the Dynamic Gait Index (DGI), which evaluates the total score and performance on functional balance tasks, comparing pre- and post-intervention values;Improvement in motor function is expected. The outcome will be assessed using the Unified Parkinson’s Disease Rating Scale (UPDRS) – Part III, evaluating total motor scores, comparing pre- and post-intervention values;Improvement in cognitive performance is expected. The outcome will be assessed using the Montreal Cognitive Assessment (MoCA), evaluating the total score, comparing pre- and post-intervention values | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Public ContactThiago Andrade
Universidade Federal do Triângulo Mineiro
Outcome results
None listed